Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects. It is used for the treatment of irritable bowel syndrome and other gastrointestinal disorders.
This report contains market size and forecasts of Trimebutine in global, including the following market information:
Global Trimebutine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Trimebutine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Trimebutine companies in 2021 (%)
The global Trimebutine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Trimebutine include Axcan Pharma, Aa Pharma, East Asia Pharma, Poly Pharma and Shanxi Xinbaoyuan Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Trimebutine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trimebutine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Trimebutine Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Trimebutine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Trimebutine Market Segment Percentages, by Application, 2021 (%)
Offline Channel
Online Channel
Global Trimebutine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Trimebutine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Trimebutine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Trimebutine revenues share in global market, 2021 (%)
Key companies Trimebutine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Trimebutine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Axcan Pharma
Aa Pharma
East Asia Pharma
Poly Pharma
Shanxi Xinbaoyuan Pharmaceutical